Celularity Inc. Prepaid Expense, Current
Celularity Inc. (CELU) had Prepaid Expense, Current of $6.97 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2022-05-16
- 2022-03-31: Prepaid Expense, Current $6.97M.
- 2021-12-31: Prepaid Expense, Current $7.08M.
- 2021-09-30: Prepaid Expense, Current $9.13M.
- 2020-12-31: Prepaid Expense, Current $6.58M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2022-03-31 | $6.97M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.08M 10-Q · filed 2022-05-16 |
| 2021-09-30 | $9.13M 10-Q · filed 2021-11-12 |
| 2020-12-31 | $6.58M 10-K · filed 2022-03-31 |
| 2020-09-30 | $65.94K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $98.25K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $118.98K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $92.15K 10-Q · filed 2020-11-16 |
| 2019-09-30 | $127.91K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $134.94K 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |